. Author manuscript; available in PMC: 2015 Jan 1.

Published in final edited form as: J Neurol Neurosurg Psychiatry. 2013 Aug 26;85(2):168–173. doi: 10.1136/jnnp-2013-305979

Table 3.

Outcome for 144 patients with MBD, by mode of treatment

	Treated with thiamine n=103	Not treated with thiamine n=41^*	Treated with steroids n=19	Not treated with steroids n=125^*

Outcome	n (%)	n (%)	n (%)	n (%)
Normal	17 (16·5)	4 (8·0)	4 (21·1)	17 (13·6)
Minimal disability	24 (23·3)	6 (12·0)	1 (5·3)	29 (23·2)
Moderate disability	29 (28·2)	12 (24·0)	5 (26·3)	36 (28·8)
Severe disability	18 (17·5)	7 (14·0)	5 (26·3)	20 (16·0)
Vegetative state	3 (2·9)	2 (4·0)	1 (5·3)	4 (3·2)
Dead	12 (11·7)	10 (20·0)	3 (15·8)	19 (15·2)

Not treated or information on treatment not available

p=0.027 for the difference in linear trend between the thiamine and outcome groups.